| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 73,980 | 75,528 | 77,381 | 75,493 | | Cost of Revenue | 22,002 | 22,935 | 23,322 | 24,000 | | | Gross Profit | 51,978 | 52,593 | 54,059 | 51,493 | | | Operating Expenses | | Research Development | 11,302 | 11,171 | 10,137 | 9,479 | | Selling General and Administrative | 17,238 | 16,757 | 17,674 | 15,391 | | Non Recurring | (127) | 127 |
-
| 160,108 | | Others | 8,065 | 7,992 | 7,547 | 7,794 | | | | Total Operating Expenses | 36,478 | 36,047 |
-
| 192,772 | | | | Operating Income or Loss | 15,195 | 16,546 | 18,701 | (141,279) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (137) | 100 | 193 | 640 | | Earnings Before Interest And Taxes | 15,363 | 16,646 | 18,894 | (140,639) | | Interest Expense | 5,154 | 5,173 | 5,386 | 5,583 | | Income Before Tax | 10,209 | 11,473 | 13,508 | (146,222) | | Income Tax Expense | 2,426 | 4,262 | 4,981 | 2,872 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,783 | 7,211 | 8,527 | (149,094) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,783 | 7,211 | 8,527 | (149,094) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,783 | $7,211 | $8,527 | ($149,094) |
|
0.02% Nasdaq 0.00%
Income Statement
